Over the past 15 years, an estimated 5 million cases of chikungunya have surfaced globally. This virus poses an escalating menace, having affected over half of the world’s nations. Recent cases in Spain, Italy, and France underscore its widespread reach. Additionally, the virus has expanded to new geographical areas, contributing to an increase in the worldwide prevalence of the disease.
Originating in Tanzania in 1952, chikungunya remains elusive to treatment, posing a potentially fatal risk to infants. In adults, it triggers fever and joint pain, accompanied by symptoms like headaches, muscle pain, rash, and joint inflammation. These effects may endure for months...
